<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Zinc chloride: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Zinc chloride: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Zinc chloride: Drug information</div><div class="clear"></div><div id="topicText"><div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
(For additional information <a class="drug drug_patient" data-topicid="12156" href="/d/html/12156.html" rel="external">see "Zinc chloride: Patient drug information"</a> and <a class="drug drug_pediatric" data-topicid="88580" href="/d/html/88580.html" rel="external">see "Zinc chloride: Pediatric drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F235727"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Trace Element</li></ul></div>
<div class="block doa drugH1Div" id="F235722"><span class="drugH1">Dosing: Adult</span>
<p style="text-indent:0em;display:inline">
<b>Note: Dosing units: </b>All dosages are expressed as elemental zinc unless stated otherwise.</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="c6ddc184-6e5a-4727-9f62-02484be5592f">Parenteral nutrition additive, maintenance requirement</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Parenteral nutrition additive, maintenance requirement:</b>
<b>Note:</b> Individualize dose based on the patient's clinical condition, nutritional requirements, and the contribution of oral or enteral zinc intake.</p>
<p style="text-indent:-2em;margin-left:4em;">Acute metabolic states: <b>IV: </b>Optimal dose not determined; monitor and replace as clinically indicated. Expert consensus recommendations suggest: 2.5 to 6.5 mg/day (Blaauw 2019).</p>
<p style="text-indent:-2em;margin-left:4em;">Metabolically stable: <b>IV:</b> 3 to 5 mg/day (ASPEN 2020).</p>
<p style="text-indent:-2em;margin-left:4em;">Replacement for small bowel fluid loss (metabolically stable): <b>IV</b>: Additional zinc replacement may be required due to excessive zinc loss in patients with high-output intestinal fistula, ostomy effluent, or severe diarrhea. Estimated loss ranges from up to an additional 12 mg of zinc per L for small bowel fluid loss or an additional ~17 mg of zinc per kg of stool or ileostomy output (Blaauw 2019; Jeejeebhoy 2009; Vanek 2012; manufacturer's labeling).</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50991834"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling. However, dosage adjustment may be necessary in severe impairment since zinc is primarily renally excreted. Additionally, aluminum accumulation may occur in the setting of renal impairment.</p></div>
<div class="block doha drugH1Div" id="F50989121"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block doe drugH1Div" id="F235723"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block dop drugH1Div" id="F235724"><span class="drugH1">Dosing: Pediatric</span><p>(For additional information <a class="drug drug_pediatric" data-topicid="88580" href="/d/html/88580.html" rel="external">see "Zinc chloride: Pediatric drug information"</a>)</p>
<p style="text-indent:0em;display:inline">
<b>Note:</b> Dosages may be presented in units of mcg or mg, use caution to ensure correct units. Clinical response may not occur for up to 6 to 8 weeks:</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="3e9cdd60-f47f-4fe0-bbeb-8e9f26c8d5ff">Parenteral nutrition, maintenance zinc requirement</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Parenteral nutrition, maintenance zinc requirement:</b>
<b>Note:</b> Higher doses may be needed if impaired intestinal absorption or an excessive loss of zinc (eg, excessive, prolonged diarrhea, high-output intestinal fistula, burns).</p>
<p style="text-indent:-2em;margin-left:4em;">Age-directed dosing (ASPEN [Vanek 2012]):</p>
<p style="text-indent:-2em;margin-left:6em;">Infants &lt;3 months: IV: 250 mcg/kg/day <b>elemental</b> zinc as an additive to parenteral nutrition solution.</p>
<p style="text-indent:-2em;margin-left:6em;">Infants ≥3 months: IV: 50 mcg/kg/day <b>elemental</b> zinc as an additive to parenteral nutrition solution.</p>
<p style="text-indent:-2em;margin-left:6em;">Children: 50 mcg/kg/day <b>elemental</b> zinc as an additive to parenteral nutrition solution; maximum daily dose: 5,000 mcg/<b>day</b>.</p>
<p style="text-indent:-2em;margin-left:4em;">Weight-directed dosing (ASPEN [Mirtallo 2004]):</p>
<p style="text-indent:-2em;margin-left:6em;">Infants &lt;10 kg: 50 to 250 mcg/kg/day <b>elemental</b> zinc as an additive to parenteral nutrition solution.</p>
<p style="text-indent:-2em;margin-left:6em;">Children 10 to 40 kg: 50 to 125 mcg/kg/day <b>elemental</b> zinc as an additive to parenteral nutrition solution; maximum daily dose: 5,000 mcg/<b>day</b>.</p>
<p style="text-indent:-2em;margin-left:6em;">Children and Adolescents &gt;40 kg: 2,000 to 5,000 mcg/<b>day </b>
<b>elemental</b> zinc as an additive to parenteral nutrition solution.</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51193576"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling; however, dosage adjustments may be necessary in severe impairment. In addition, aluminum accumulation may occur in the setting of renal impairment.</p></div>
<div class="block dohp drugH1Div" id="F51193577"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block adr drugH1Div" id="F235714"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;">&lt;1%, postmarketing, and/or case reports: Dyspepsia, hypotension, jaundice, leukopenia, nausea, neutropenia, pulmonary edema, vomiting</p></div>
<div class="block coi drugH1Div" id="F57852116"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;">Direct IM or IV injection.</p></div>
<div class="block war drugH1Div" id="F13880761"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Disease-related concerns:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Renal impairment: Use with caution in patients with renal impairment.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concurrent drug therapy issues:</i></b></p>
<p style="text-indent:-4em;margin-left:6em;">• Copper: Chronic administration of high-dose zinc may cause a decrease in enteral copper absorption and subsequent decreased copper deficiency (Kumar 2022; Marumo 2021; manufacturer's labeling).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Dosage form specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Aluminum: The parenteral product may contain aluminum; toxic aluminum concentrations may be seen with high doses, prolonged use, or renal dysfunction. Premature neonates are at higher risk due to immature renal function and aluminum intake from other parenteral sources. Parenteral aluminum exposure of &gt;4 to 5 mcg/kg/day is associated with CNS and bone toxicity; tissue loading may occur at lower doses (Federal Register 2002).</p></div>
<div class="block dosfc drugH1Div" id="F21963759"><span class="drugH1">Dosage Forms Considerations</span>
<p style="text-indent:0em;display:inline">Strength of zinc chloride injection is expressed as elemental zinc</p></div>
<div class="block foc drugH1Div" id="F235718"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Intravenous [preservative free]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 1 mg/mL (10 mL)</p></div>
<div class="block geq drugH1Div" id="F235709"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F54082354"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Zinc Chloride Intravenous)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1 mg/mL (per mL): $2.84</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block adm drugH1Div" id="F50858830"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">
<b>IV:</b> Do not administer IM or by direct IV infusion; acidic pH of the solution may cause tissue irritation. Must be prepared and used as an admixture in parenteral nutrition solutions only. Administer after dilution in volume of fluid ≥100 mL.</p></div>
<div class="block admp drugH1Div" id="F52614029"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">IV: Dilute as component of daily parenteral nutrition or maintenance fluids; do not give undiluted by direct injection into a peripheral vein due to potential for phlebitis and tissue irritation and potential to increase renal losses of minerals from a bolus injection </p></div>
<div class="block use drugH1Div" id="F235719"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:0em;">
<b>Parenteral nutrition additive, maintenance requirement:</b> Trace element added to parenteral nutrition to prevent deficiency.</p></div>
<div class="block cyt drugH1Div" id="F13300236"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F6223728"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Dolutegravir: Zinc Salts may decrease the serum concentration of Dolutegravir.  Management: Administer dolutegravir at least 2 hours before or 6 hours after oral zinc salts. Administer the dolutegravir/rilpivirine combination product at least 4 hours before or 6 hours after oral zinc salts.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Levonadifloxacin: Zinc Salts may decrease the serum concentration of Levonadifloxacin. <i> Risk X: Avoid combination</i></p></div>
<div class="block pri drugH1Div" id="F13880759"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;display:inline">Zinc crosses the placenta and can be measured in the cord blood and placenta. Fetal concentrations are regulated by the placenta (de Moraes 2011).</p></div>
<div class="block brc drugH1Div" id="F13880760"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:0em;display:inline">Zinc is found in breast milk; concentrations decrease over the first 6 months of lactation. Concentrations are generally not affected by dietary supplementation (IOM 2001)</p></div>
<div class="block mop drugH1Div" id="F50858832"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Periodic serum copper and serum zinc levels (patients on parenteral nutrition or chronic therapy); alkaline phosphatase, taste acuity, mental depression.</p></div>
<div class="block rer drugH1Div" id="F58899852"><span class="drugH1">Reference Range</span>
<p style="text-indent:0em;display:inline">Zinc, serum: 75 to 140 mcg/dL (11.5 to 21.4 mmol/L) (ABIM 2023). <b>Note:</b> Serum zinc concentrations are dependent on age and sex, and may fluctuate depending on time of blood draw, infection, hormone changes, and muscle catabolism; correlation with clinical signs and/or symptoms of zinc deficiency is recommended (NIH 2022).</p></div>
<div class="block phk drugH1Div" id="F46169260"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Distribution: Stored primarily in skeletal muscle and bone (&gt;85%) (IOM 2001).</p>
<p style="text-indent:-2em;margin-left:2em;">Protein binding: Albumin and alpha 1-macroglobulin (Foote 1984).</p>
<p style="text-indent:-2em;margin-left:2em;">Excretion: Feces and urine (IOM 2001).</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F5549683"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(FI)</span> <span class="country">Finland</span><span class="countrySeparator">: </span><span class="drugName">Sinkkisteril | Zincfusin</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">Zincshot</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference">
                  Aluminum in large and small volume parenterals used in total parenteral nutrition. <i>Fed Regist</i>. 2002;67(244):77792-77793. To be codified at 21 CFR §201.323.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-ABIM.1">
<a name="ABIM.1"></a>American Board of Internal Medicine (ABIM). Laboratory test reference ranges, 2023. https://www.abim.org/Media/bfijryql/laboratory-reference-ranges.pdf. Updated July 2023. Accessed December 6, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-ASPEN.1">
<a name="ASPEN.1"></a>American Society for Parenteral and Enteral Nutrition (ASPEN). Appropriate dosing for parenteral nutrition: ASPEN recommendations. https://www.nutritioncare.org/uploadedFiles/Documents/Guidelines_and_Clinical_Resources/PN%20Dosing%201-Sheet-Nov%202020-FINAL.pdf. Updated November 17, 2020. Accessed December 2, 2022.</div>
</li>
<li>
<div class="reference">
                  Anderson LA, Hakojarvi SL, Boudreaux SK. Zinc acetate treatment in Wilson's disease. <i>Ann Pharmacother</i>. 1998;32(1):78-87.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30812055">
<a name="30812055"></a>Blaauw R, Osland E, Sriram K, et al. Parenteral provision of micronutrients to adult patients: an expert consensus paper. <i>JPEN J Parenter Enteral Nutr</i>. 2019;43(suppl 1):S5-S23. doi:10.1002/jpen.1525<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-chloride-drug-information/abstract-text/30812055/pubmed" id="30812055" target="_blank">30812055</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20195918">
<a name="20195918"></a>de Moraes ML, de Faria Barbosa R, Santo RE, et al, "Maternal-Fetal Distribution of Calcium, Iron, Copper, and Zinc in Pregnant Teenagers and Adults," <i>Biol Trace Elem Res</i>, 2011, 139(2):126-36.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-chloride-drug-information/abstract-text/20195918/pubmed" id="20195918" target="_blank">20195918</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6206098">
<a name="6206098"></a>Foote JW, Delves HT. Albumin bound and alpha 2-macroglobulin bound zinc concentrations in the sera of healthy adults. <i>J Clin Pathol</i>. 1984;37(9):1050‐1054.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-chloride-drug-information/abstract-text/6206098/pubmed" id="6206098" target="_blank">6206098</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Institute of Medicine (US) Panel on Micronutrients. <i>Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc</i>. Washington, DC: National Academies Press; 2001.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19874952">
<a name="19874952"></a>Jeejeebhoy K. Zinc: an essential trace element for parenteral nutrition. <i>Gastroenterology</i>. 2009;137(5)(suppl):S7-S12. doi:10.1053/j.gastro.2009.08.014<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-chloride-drug-information/abstract-text/19874952/pubmed" id="19874952" target="_blank">19874952</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35971347">
<a name="35971347"></a>Kumar M, Nanja Reddy S, Ismail R. Copper and zinc feud: is this myelodysplasia or myelodysplastic syndrome? <i>Cureus</i>. 2022;14(7):e26789. doi:10.7759/cureus.26789<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-chloride-drug-information/abstract-text/35971347/pubmed" id="35971347" target="_blank">35971347</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25681484">
<a name="25681484"></a>Livingstone C. Zinc: physiology, deficiency, and parenteral nutrition. <i>Nutr Clin Pract</i>. 2015;30(3):371-382.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-chloride-drug-information/abstract-text/25681484/pubmed" id="25681484" target="_blank">25681484</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34484374">
<a name="34484374"></a>Marumo A, Yamamura T, Mizuki T, Tanosaki S, Suzuki K. Copper deficiency-induced pancytopenia after taking an excessive amount of zinc formulation during maintenance hemodialysis. <i>J Res Med Sci</i>. 2021;26:42. doi:10.4103/jrms.JRMS_25_19<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-chloride-drug-information/abstract-text/34484374/pubmed" id="34484374" target="_blank">34484374</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15568296">
<a name="15568296"></a>Mirtallo J, Canada T, Johnson D, et al. Safe practices for parenteral nutrition. <i>JPEN J Parenter Enteral Nutr</i>. 2004;28(6):S39-70.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-chloride-drug-information/abstract-text/15568296/pubmed" id="15568296" target="_blank">15568296</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-NIH.1">
<a name="NIH.1"></a>National Institutes of Health (NIH). Zinc fact sheet for health professionals. <a href="https://ods.od.nih.gov/factsheets/Zinc-HealthProfessional/" target="_blank">https://ods.od.nih.gov/factsheets/Zinc-HealthProfessional/</a>. Updated September 28, 2022. Accessed November 30, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Manu.1">
<a name="Manu.1"></a>Refer to manufacturer’s labeling.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22730042">
<a name="22730042"></a>Vanek VW, Borum P, Buchman A, et al; Novel Nutrient Task Force, Parenteral Multi-Vitamin and Multi–Trace Element Working Group; American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. A.S.P.E.N. position paper: recommendations for changes in commercially available parenteral multivitamin and multi-trace element products. <i>Nutr Clin Pract</i>. 2012;27(4):440-491. doi:10.1177/0884533612446706<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-chloride-drug-information/abstract-text/22730042/pubmed" id="22730042" target="_blank">22730042</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-ZincChloride.2004.10">
<a name="ZincChloride.2004.10"></a>Zinc chloride injection [prescribing information]. Lake Forest, IL: Hospira Inc; August 2020.</div>
</li></ol></div><div id="topicVersionRevision">Topic 10325 Version 154.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
